June 8, 2007 β Haemoscope Corporation has developed PlateletMapping assays, combining automated platelet aggregation ...
June 8, 2007 β CardiArc, Inc. has established a research and testing program in which CardiArc SPECT system devices will ...
June 7, 2007 β NASA space technology is helping doctors diagnose and monitor treatments for hardening of the arteries in ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 5, 2007 - GVI Medical Devices, Inc., extended its nuclear cardiology line with the introduction of ClearVision ...
June 5, 2007 β A patch designed to help damaged cardiac tissue recover from a heart attack has been successful in early ...
June 5, 2007 - Photon2 announced that it has received FDA approval for its new compact cardiac camera. The C! is a gamma camera designed for cardiologists in the diagnosis of cardiac disease.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
June 5, 2007 β Men whose blood tests positive for the auto-antibody rheumatoid factor have a three times higher risk of ...
June 5, 2007 - Siemens Medical Solutions Molecular Imaging division demonstrated three new syngo software packages ...
June 4, 2007 β Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AspirinWorks Test Kit, the Company's newest diagnostic product.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 5, 2007 - GE Healthcare introduced at SNM a new version of the companyβs Discovery Dimension designed to help ...
June 4, 2007 β Biodegradable magnesium stents have been developed to treat blockages in coronary arteries. The stents will degrade within four months and achieve the same results as conventional stents, conclude authors of an article published in this week's edition of The Lancet.
June 4, 2007 β Contrary to recent studies, proper use of a drug called aprotinin to reduce bleeding during heart surgery does not increase the risk of heart attack or stroke, according to a study in the June issue of The Journal of Thoracic and Cardiovascular Surgery.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
June 4, 2007 β A new radiological test, used to detect acute coronary trauma has the ability to save valuable time and ...
June 1, 2007 β New findings show that the majority of people untrained in how to perform cardiopulmonary resuscitation ...
June 1, 2007 β Abbott announced it has completed its application to the U.S. Food and Drug Administration (FDA) to seek market approval for its XIENCE V Everolimus Eluting Coronary Stent System to treat coronary artery disease, with the submission of the final module of its Pre-Market Approval (PMA) application.